Skip to content
PICO Portalanswers from OpenAlex

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.

PaperCitations, authors & open-access status

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. have?

PICO Portalcitation count

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. has 22 citations in the OpenAlex counts PICO Portal stores.

When was Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. published?

PICO Portalyear

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. has 2002 year in the PICO Portal index.

What is the open-access status of Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.?

PICO Portaloa status

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. has closed oa status in the PICO Portal index.

What is the DOI of Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.?

PICO Portaldoi

The DOI for Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. is on the source record.

What is the PMID of Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.?

PICO Portalpmid

The PMID for Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. is on the source record.

What is the OpenAlex record for Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.?

PICO Portalopenalex

The OpenAlex for Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment. is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial